RPA-CRISPR / Cas12a detection system, application and detection method for hookworm of Duodenum
By using the RPA-CRISPR/Cas12a detection system and targeting the ITS1-5.8SrRNA-ITS2-28SrRNA (partial) genes, combined with RPA amplification and CRISPR/Cas12a reaction, rapid, sensitive and specific detection of hookworm of the duodenum was achieved, solving the problems of long detection time and low sensitivity in existing technologies.
Patent Information
- Application Number
- CN202610582680.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-04-29
- Publication Date
- 2026-11-17
AI Technical Summary
Existing hookworm detection technologies suffer from low sensitivity, poor specificity, complex operation, and long detection time for detecting duodenal hookworm, making it difficult to meet the demand for rapid and accurate detection.
The RPA-CRISPR/Cas12a detection system utilizes the ITS1-5.8SrRNA-ITS2-28SrRNA (partial) genes as detection targets. By combining RPA amplification primer pairs and the CRISPR/Cas12a system, rapid and sensitive detection is achieved through the specific recognition and cleavage of CRISPR/Cas12a protein and crRNA.
It achieves highly sensitive, specific, easy-to-operate, and short-time detection of hookworms of the duodenum, which can be completed within 60 minutes. It can also distinguish other hookworms such as American hookworm and Trichinella spiralis, and the detection results are visualized.
Smart Images

Figure CN123108155A_ABST
Abstract
Description
Technical Field
[0001] This invention relates to the field of microbial detection technology, and in particular to an RPA-CRISPR / Cas12a detection system, its application, and a detection method for hookworm of the duodenum. Background Technology
[0002] Hookworms are a collective term for nematodes of the family Achistostomedae. The main species that parasitize humans are *Ancylostoma duodenale* and *Necator americanus*. While *Necator americanus* and *Ancylostoma duodenale* differ significantly in morphology, their life cycles are remarkably similar. When hookworm eggs are excreted in the host's feces and fall into suitable soil, they hatch into non-infectious rhabdocysts within 24 to 48 hours. These rhabdocysts then further develop into filariae, the third-stage larvae, in the feces or soil. Filamenta can survive in the environment for up to a month and invade the human body through the mouth or skin (usually barefoot contact). Once inside the body, the filariae travel through the bloodstream to the heart and lungs, then ascend along the bronchi to the pharynx and are swallowed into the gastrointestinal tract. Finally, they mature into adult worms in the small intestine, where they feed on blood and cause anemia in the host. Studies show that *Ahedrus reticulata* causes approximately 0.02 to 0.10 ml of blood loss per day in its host. In contrast, *Ahedrus duodenalis*, due to its larger size, mouth structure, and egg production, causes about ten times the blood loss of *Ahedrus reticulata*. Furthermore, hookworm disease in infants and young children is mostly caused by *Ahedrus duodenalis*.
[0003] Hookworm disease is prevalent in rural and impoverished areas of tropical and subtropical developing countries. It is a neglected tropical disease and one of the important public health problems. Hookworm disease causes more than 4 million disability-adjusted life years (DALYs) loss worldwide each year and has an economic impact of more than US$100 billion on the world each year. In recent years, with the improvement of sanitation conditions and the strengthening of prevention and control measures, the incidence of hookworm disease has shown a low infection rate. According to the "Third National Survey Report on the Status of Key Human Parasitic Diseases" [8], hookworm is the most common soil-transmitted nematode in the eastern monsoon ecological zone. Hookworm infection has been found in all 19 provinces of the country. Among the hookworm species in the country, the proportion of American hookworm is 78.46%, the proportion of duodenal hookworm is 13.38%, and the proportion of combined infection is 8.16%. Two provinces have only American hookworm infection and six provinces have only duodenal hookworm infection. Both types of worm infection exist in 11 provinces.
[0004] Existing hookworm detection technologies for *Ahedrus duodenalis* include etiological detection, immunological detection, and molecular biological detection. However, these methods have the following drawbacks: etiological detection techniques are simple to operate and suitable for field testing, but are time-consuming and labor-intensive, have low sensitivity and cannot identify species, require highly specialized personnel, and are prone to false negatives and missed positives; immunological detection techniques can achieve rapid on-site detection, but their sensitivity and species specificity are poor, and they cannot distinguish between past and current infections; molecular biological detection techniques can meet current hookworm detection needs, with PCR, LAMP, and RPA technologies commonly used, but they have certain requirements for the testing environment and facilities, and the testing time is long, limiting their on-site application. Furthermore, most of these methods are for *Ahedrus reticulata*, with fewer nucleic acid detection methods for *Ahedrus duodenalis*.
[0005] Therefore, there is an urgent need in this field for a highly sensitive, specific, easy-to-operate, and short-time detection method for hookworm of the duodenum, which can avoid the drawbacks of etiological microscopy, immunological detection, and existing molecular biological techniques, and efficiently, rapidly, and accurately detect hookworm target genes and meet the needs of disease detection and screening. Summary of the Invention
[0006] The technical problem to be solved by the present invention is to provide an RPA-CRISPR / Cas12a detection system, its application and detection method for hookworm of duodenum. When using this detection system to detect hookworm of duodenum, it has high sensitivity, strong specificity, convenient operation and short detection time.
[0007] To address the aforementioned technical problems, one aspect of the present invention is to provide an RPA-CRISPR / Cas12a detection system for hookworm of the duodenum, using the ITS1-5.8S rRNA-ITS2-28S rRNA (partial) genes as detection targets, wherein the detection system comprises: The RPA amplification system contains RPA amplification primer pairs, wherein the RPA amplification primer pairs are the first primer pair F1R1 and / or the second primer pair F1R2; The CRISPR / Cas12a system contains crRNA, which is ITS crRNA1. The sequence of the upstream primer F1 of the first primer pair is: 5'-CTTACTGCTTGTGTTGGTGGTTGAGCATTAG-3'; The sequence of the downstream primer R1 of the first primer pair is: 5'-CTGTAGTAGATATAAACAACCCTGAACCAGAC-3'; The sequence of the upstream primer F1 of the second primer pair is: 5'-CTTACTGCTTGTGTTGGTGGTTGAGCATTAG-3'; The sequence of the downstream primer R2 of the second primer pair is: 5'-CGTCTGCAATTCGTGGTAAATAACGCAGCTA-3'; The sequence of ITS crRNA1 is: 5'-UAAUUUCUACUAAGUGUAGAUACGUUUAAUGUUUGCAGAAU-3'.
[0008] In this invention, ITS1-5.8SrRNA-ITS2-28SrRNA (partial) are conserved genes of hookworm of the duodenum. Using them as gene targets for detecting hookworm of the duodenum helps to improve the accuracy of detection. The RPA-CRISPR / Cas12a detection system of this invention includes at least one of the following two primer and crRNA combinations: F1R1 and ITScrRNA1 combination, and F1R2 and ITScrRNA1 combination.
[0009] In one specific embodiment, the RPA amplification system further includes a positive plasmid standard, a lyophilized enzyme complex, a buffer solution, magnesium acetate, and ultrapure water. Preferably, the positive plasmid standard is a plasmid containing the ITS1-5.8SrRNA-ITS2-28SrRNA (partial) gene; the lyophilized enzyme complex includes recombinase, polymerase, single-stranded binding protein, and dNTP / dNTPase; it should be noted that the buffer solution is not particularly required in this invention, and conventional buffer solutions for RPA amplification in the prior art can be used as needed.
[0010] In one specific embodiment, the CRISPR / Cas12a system further includes ssDNA, Cas12a protein, RNase inhibitor, buffer, and ultrapure water. The ssDNA sequence is TTATT, with the 5' end labeled with a fluorescent reporter group FAM and the 3' end labeled with a fluorescent quencher group BHQ1. Preferably, in the CRISPR / Cas12a system, the concentration of Cas12a protein is 20-80 nM, the concentration of crRNA is 20-80 nM, the concentration of ssDNA is 100-140 nM, and the concentration of RNase inhibitor is 0.8-1.3 U / µL, wherein the molar ratio of Cas12a protein to crRNA is 1:0.5-1.5. It should be noted that the buffer is not particularly required in this invention, and conventional buffers for CRISPR / Cas12a systems in the prior art can be used in this invention as needed.
[0011] In this invention, primer pairs are used to amplify the target gene during RPA amplification. The Cas12a protein recognizes and binds to the target gene with crRNA. The crRNA specifically targets the target gene. After the Cas12a protein is activated, it rapidly cleaves the target gene. At the same time, the non-specific trans-cleavage effect is activated, the ssDNA in the reaction system is reverse-cleaved, the FAM-labeled fluorescent probe on the ssDNA is dissolved, and BHQ2 loses its quenching effect, thereby generating a fluorescent signal.
[0012] To address the aforementioned technical problems, a second aspect of the present invention is to provide the application of the aforementioned detection system in the preparation of products for detecting hookworm of the duodenum. For example, its application in the preparation of a hookworm detection kit.
[0013] To address the aforementioned technical problems, a third advantage of the present invention is to provide a non-diagnostic method for detecting hookworm in the duodenum, comprising the following steps: S1. Extract DNA from the sample to be tested; S2. The obtained DNA is subjected to RPA amplification using the RPA amplification system described in claim 1 to obtain amplification products; S3. Add the amplification product obtained in step S2 to the CRISPR / Cas12a system described in claim 1, and perform a CRISPR / Cas12a reaction on the amplification product. S4. Determine whether hookworms of the duodenum are detected by fluorescence detection.
[0014] In one specific embodiment, in step S2, the RPA amplification system is prepared as follows: RPA amplification primer pairs (F1R1 and / or F1R2), buffer, and ultrapure water are premixed, then a lyophilized enzyme complex is added, mixed thoroughly, and then a positive plasmid standard and magnesium acetate are added to obtain the RPA amplification system. Preferably, in step S2, the positive plasmid standard is a plasmid containing the ITS1-5.8SrRNA-ITS2-28SrRNA (partial) gene. The lyophilized enzyme complex includes recombinase, polymerase, single-stranded binding protein, and dNTP / dNTPase. It should be noted that this specific scheme does not have special requirements for the buffer; conventional buffers for RPA amplification systems are suitable.
[0015] In step S3, the CRISPR / Cas12a system is prepared by mixing Cas12a protein, crRNA (ITScrRNA1), ssDNA, RNase inhibitor, buffer, and ultrapure water until homogeneous. Preferably, the ssDNA sequence is TTATT, wherein the 5' end is labeled with the fluorescent reporter group FAM, and the 3' end is labeled with the fluorescent quencher group BHQ1. The concentrations of Cas12a protein and crRNA were 20-80 nM, ssDNA was 100-140 nM, and RNase inhibitor was 0.8-1.3 U / µL. The molar ratio of Cas12a protein to crRNA was 1:0.5-1.5.
[0016] The non-diagnostic method for detecting hookworm in the duodenum provided by this invention has an RPA amplification time of 15-40 min and a CRISPR / Cas12a detection time of 15-40 min, with the sum of the total RPA amplification time and CRISPR / Cas12a detection time not exceeding 60 min, and a minimum of 40 min, resulting in a short detection time. Verification has shown that neither primer combination exhibits cross-reactivity with hookworm, trichinella, anisakis, echinococcosis multilocularis, echinococcosis granulosus, or schistosome japonicus, demonstrating good specificity. Furthermore, the generated fluorescence can be read using a portable blue light device, making the detection results visual and highly practical. This invention also boasts high sensitivity, with a detection limit as low as 10 copies / μL. Attached Figure Description
[0017] To more clearly illustrate the technical solution of the present invention, the accompanying drawings used in the present invention will be briefly introduced below. Obviously, the drawings described below are only some embodiments of the present invention. For those skilled in the art, other drawings can be obtained based on these drawings without creative effort.
[0018] Figure 1 This is a characteristic amplification curve diagram of the ITS1-5.8S rRNA-ITS2-28S rRNA (partial) gene crRNA screening. Figure 2 This is a characteristic amplification curve of the ITS1-5.8S rRNA-ITS2-28S rRNA (partial) gene F1R1-crRNA1 combination Cas12a and crRNA concentration screening. Figure 3 This is a characteristic amplification curve of the ITS1-5.8S rRNA-ITS2-28S rRNA (partial) gene F1R2-crRNA1 combination Cas12a and crRNA concentration screening. Figure 4 This is a characteristic amplification curve diagram of the ssDNA concentration screening test; Figure 5 This is a characteristic amplification curve of the reaction time of the ITS1-5.8S rRNA-ITS2-28S rRNA (partial) gene F1R1-crRNA1 combination. Figure 6 This is a characteristic curve of the reaction time amplification curve of the ITS1-5.8S rRNA-ITS2-28S rRNA (partial) gene F1R2-crRNA1 combination; Figure 7 This is a characteristic curve of the temperature amplification curve of the combined reaction of ITS1-5.8S rRNA-ITS2-28S rRNA (partial) gene F1R1-crRNA1. Figure 8 This is a characteristic curve of the temperature amplification curve of the combined reaction of ITS1-5.8S rRNA-ITS2-28S rRNA (partial) gene F1R2-crRNA1; Figure 9 This is a characteristic curve diagram of the cross-reaction experiment of ITS1-5.8S rRNA-ITS2-28S rRNA (partial) gene F1R1-crRNA1. Figure 10 This is a characteristic curve diagram of the cross-reactivity experiment of ITS1-5.8S rRNA-ITS2-28S rRNA (partial) gene F1R2-crRNA1. Figure 11 This is a characteristic amplification curve diagram for the detection limit determination of the F1R1-crRNA1 gene of ITS1-5.8S rRNA-ITS2-28S rRNA (partial). Figure 12 This is a characteristic curve diagram of the amplification curve for the detection limit determination of the ITS1-5.8S rRNA-ITS2-28S rRNA (partial) gene F1R2-crRNA1. Figure 13 This is a characteristic graph of the amplification curves for samples 1-17 based on RPA-CRISPR / Cas12a; Figure 14 This is a characteristic curve of the amplification curve for samples 18-37 based on RPA-CRISPR / Cas12a. Figure 15 This is a graph showing the blue light transilluminator results of samples 1-17 based on RPA-CRISPR / Cas12a. Figure 16 This is a graph showing the blue light transilluminator results of sample 18-37 based on RPA-CRISPR / Cas12a. Detailed Implementation
[0019] The technical solutions of the present invention will now be clearly and completely described with reference to the accompanying drawings. Obviously, the described embodiments are only some, not all, of the embodiments of the present invention. All other embodiments obtained by those skilled in the art based on the embodiments of the present invention without creative effort are within the scope of protection of the present invention.
[0020] Example 1: Establishment and Optimization of RPA-CRISPR / Cas12a Detection System I. RPA Amplification System 1. Design and synthesis of RPA amplification primer pairs Based on the published complete mitochondrial genome sequence of *Hookworm* (accession number: NC_003415.1) in GenBank and the *Hookworm* ITS1-5.8S rRNA-ITS2-28S rRNA (partial) gene (EU344797), primers were designed according to the RPA technical guidelines published by TwistDx. Three pairs of forward and reverse primers were designed for the target gene ITS1-5.8S rRNA-ITS2-28S rRNA (partial) (see Table 1). Secondary structure prediction and free energy calculation were performed using Primer Premier 6.0 software, supplemented by artificial base modification optimization. All primer sequences were synthesized by Sangon Biotech (Shanghai) Co., Ltd.
[0021] Table 1
[0022] 2. Preliminary screening of RPA amplification primer pairs 1) Construction of positive plasmid: After activating and culturing the bacterial culture containing the ITS1-5.8SrRNA-ITS2-28SrRNA (partial) gene plasmid (purchased from BGI Genomics Co., Ltd.), plasmid DNA was extracted (based on the TIANGEN plasmid miniprep kit). Sequencing and analysis were then performed to confirm the successful construction of the positive plasmid. The plasmid was then stored at -20℃ for later use.
[0023] 2) Preliminary screening of RPA amplification primer pairs: The designed ITS1-5.8S rRNA-ITS2-28S rRNA (partial) gene primer pair was used to amplify the gene using the constructed plasmid containing the ITS1-5.8S rRNA-ITS2-28S rRNA (partial) gene as a template. The amplified products were purified using the OMEGA nucleic acid purification kit (D6492-01). The purified DNA fragments were electrophoresed on a 1.5% agarose gel in a 1×TAE buffer at a constant voltage of 110V for 45 minutes. UV excitation fluorescence detection was then performed using a Bio-Rad Gel Doc XR+ imaging system, and the results were observed and recorded. Products from samples meeting the expected fragment size, with clear main bands and no tailing were sent to BGI Genomics for bidirectional Sanger sequencing. The sequencing results were compared for homology using the NCBI BLASTn database. The amplification products of some primer pairs showed less than 85% homology between the target sequence and other species of hookworm (such as *Hookworm spp.*) according to BLASTn alignment, and the sequencing peak quality was excellent, indicating excellent specificity, which could be used for subsequent experiments. The final selected primers will undergo three replicate validations to ensure the reliability of the experimental results. Two primer pairs were selected: the ITS1-5.8S rRNA-ITS2-28S rRNA (partial) gene primer pairs F1R1 (321 bp) and F1R2 (237 bp).
[0024] II. CRISPR / Cas12a System 1. Reporter molecule ssDNA synthesis The CRISPR / Cas12a system triggers a cascade reaction through crRNA-mediated target sequence recognition. It recognizes the target sequence and performs cis-cleavage to specifically cleave double-stranded target DNA, thereby activating non-specific trans-cleavage to achieve indiscriminate degradation of any single-stranded nucleic acid molecule in the reaction system. Since the Cas12a protein has better cleavage activity against adenine A and thymine T, the basic sequence of ssDNA is chosen as TTATT, with a fluorescent reporter group FAM added to the 5' end and a fluorescent quencher group BHQ1 added to the 3' end. When the system is not activated by the target, the probe remains in a fluorescence-silent state through the FRET effect between the luciferin and the quencher group. After the Cas12a trans-cleavage activity is activated, the single-stranded DNA probe is randomly cleaved, causing the luciferin and the quencher group to separate spatially and emit fluorescence. The ssDNA sequence is: 5'-FAM-TTATT-BHQ1-3'.
[0025] 2. crRNA design, synthesis, and screening A LbCas12a protein-specific binding domain (UAAUUUCUACUAAGUGUAGAU) was fused to the 5' end of the crRNA, and a target sequence was inserted at the 3' end as a forward primer, ensuring its orientation was homologous and complementary to the reverse complementary strand of the RPA amplification product, thus constructing a crRNA adapted to the isothermal amplification product. The target-designed crRNA was located in the amplification region of the target primer pair, and its secondary structure stability was predicted. The NCBI Primer-BLAST tool was used to verify that there was no cross-reactivity with the human genome. The target crRNA sequence is shown in Table 2. Table 2
[0026] After the chemical synthesis of crRNA was completed, plasmid amplification was performed using the TwistAmp Basic RPA kit (Leshan, China), and the reaction was carried out at 37℃ for 20 minutes in a real-time PCR instrument. The amplified product was purified using the D6492-02 purification kit (Omegabio-tech, USA) to remove primer dimers. 2 μL of the purified product was then mixed with LbCas12a protein (Guangzhou Megvii, China) at a final concentration of 50 nM, crRNA at a final concentration of 50 nM, and FAM-labeled ssDNA reporter probe (5'-FAM-TTATT-3'-BHQ1) at a final concentration of 100 nM. The fluorescence signal rise rate (ΔRFU / min) was monitored using a real-time PCR instrument at 37℃ for 20 minutes. Primer-crRNA combinations with shorter signal threshold time (Tt value) and higher RFU were selected for subsequent detection.
[0027] During the screening of target genes for ITS1-5.8S rRNA-ITS2-28S rRNA (partial), by comparing the amplification curve characteristics of different primer combinations, it was found that F1R1-ITS crRNA1 (hereinafter abbreviated as F1R1-crRNA1) and F1R2-ITS crRNA1 (hereinafter abbreviated as F1R2-crRNA1) exhibited highly similar fluorescence signal intensities at the same template concentration (e.g., Figure 1 As shown, P1: F1R1-ITS crRNA1; P2: F1R1-ITS crRNA2; P3: F1R2-ITS crRNA1; P4: F1R2-ITS crRNA2; NC: negative control; NTC: blank control. Considering that both can produce a stable exponential amplification phase, both primer combinations are retained as candidate schemes.
[0028] III. Establishment of RPA-CRISPR / Cas12a Detection System In this embodiment, a bilayer reaction system was constructed in a 200 μL centrifuge tube. 50 μL of RPA reaction system (containing upstream and downstream primers, recombinase polymerase mixture, template DNA, promoter, and reaction buffer) was added to the bottom of the tube, followed by 25 μL of high-purity mineral oil (density 0.84 g / cm³) as a liquid phase barrier. 25 μL of CRISPR / Cas12a fluorescence detection system was pre-placed on the tube cap. The reaction was carried out at a constant temperature of 37℃. After amplification, the system at the bottom of the centrifuge tube was mixed with the system on the cap, and the tube was centrifuged. If the amplified sample was positive, the trans-cleavage activity of the CRISPR / Cas12a system was activated, resulting in the cleavage of ssDNA and the generation of a fluorescence signal. Changes in fluorescence intensity were monitored using a real-time fluorescence detector to determine parameters such as reagent concentration, time, and temperature. Since this method does not require opening the cap during operation, it effectively reduces the risk of aerosol contamination. 1. Determination of Cas12a and crRNA concentrations This invention employs an L16(42) orthogonal experimental design method to systematically screen Cas12a nuclease and crRNA (ITScrRNA1). A Cas12a protein concentration gradient (20, 30, 40, 50 nM) is set in the experimental system, and the crRNA concentration is matched at a 1:1 molar ratio (concentrations of 20, 30, 40, 50 nM). The RPA system is placed at the bottom of the reaction tube, and 25 μL of CRISPR / Cas12a system containing Cas12a and crRNA at the corresponding concentrations is placed on the reaction tube cap. The RPA reaction is performed at 37℃ for 20 min, followed by mixing and centrifugation. The relative fluorescence intensity is observed using a real-time quantitative PCR instrument, and the fluorescence intensity is recorded every 1 min.
[0029] The combination of F1R1-crRNA1 from the ITS1-5.8S rRNA and ITS2-28S rRNA (partial) genes exhibited optimal detection performance at a concentration of 40 nM:40 nM. Figure 2As shown, among them, 1: LbCas12a: crRNA= 20 nM: 20 nM; 2: LbCas12a: crRNA= 30 nM: 20 nM; 3: LbCas12a: crRNA= 40 nM: 20 nM; 4: LbCas12a: crRNA= 50 nM: 20 nM; 5: LbCas12a: crRNA= 20 nM: 30 nM; 6: LbCas12a: crRNA= 30 nM: 30 nM; 7: LbCas12a: crRNA= 40 nM: 30 nM; 8: LbCas12a: crRNA= 50nM: 30 nM; 9: LbCas12a: crRNA= 20 nM: 40 nM; 10: LbCas12a: crRNA= 30 nM: 40 nM; 11: LbCas12a:crRNA = 40 nM: 40 nM; 12: LbCas12a:crRNA = 50 nM: 40 nM; 13: LbCas12a:crRNA = 20 nM: 50 nM; 14: LbCas12a:crRNA = 30 nM: 50 nM; 15: LbCas12a:crRNA = 40 nM: 50 nM; 16: LbCas12a:crRNA = 50 nM: 50 nM; NC: Negative control; NTC: Blank control.
[0030] The combination of F1R2-crRNA1 from the ITS1-5.8S rRNA and ITS2-28S rRNA (partial) genes exhibited optimal detection performance at a concentration of 50 nM:50 nM. Figure 3As shown, among them, 1: LbCas12a: crRNA= 20 nM: 20 nM; 2: LbCas12a: crRNA= 30 nM: 20 nM; 3: LbCas12a: crRNA= 40 nM: 20 nM; 4: LbCas12a: crRNA= 50 nM: 20 nM; 5: LbCas12a: crRNA= 20 nM: 30 nM; 6: LbCas12a: crRNA= 30 nM: 30 nM; 7: LbCas12a: crRNA= 40 nM: 30 nM; 8: LbCas12a: crRNA= 50nM: 30 nM; 9: LbCas12a: crRNA= 20 nM: 40 nM; 10: LbCas12a: crRNA= 30 nM: 40 nM; 11: LbCas12a:crRNA = 40 nM: 40 nM; 12: LbCas12a:crRNA = 50 nM: 40 nM; 13: LbCas12a:crRNA = 20 nM: 50 nM; 14: LbCas12a:crRNA = 30 nM: 50 nM; 15: LbCas12a:crRNA = 40 nM: 50 nM; 16: LbCas12a:crRNA = 50 nM: 50 nM; NC: Negative control; NTC: Blank control.
[0031] It can be seen that the concentration of Cas12a protein is 40-50 nM, the concentration of crRNA is 40-50 nM, and the molar ratio of Cas12a protein to crRNA is 1:1.
[0032] 2. Determination of ssDNA concentration This invention employs a gradient experiment to screen ssDNA concentrations (60, 80, 100, 120, 140 nM). The RPA system is placed at the bottom of the reaction tube, and 25 μL of CRISPR / Cas12a system containing the corresponding ssDNA concentration is placed on the tube cap. The RPA reaction is carried out at 37°C for 20 min, followed by mixing and centrifugation. The relative fluorescence intensity is observed using a real-time quantitative PCR instrument, with fluorescence intensity recorded every 1 min. The detection performance is best when the ssDNA concentration is between 100-140 nM, especially at 100 nM, where the detection performance is optimal and the detection benefit is greatest. Figure 4 As shown, NC represents the negative control, and NTC represents the blank control. Therefore, the ssDNA concentration was determined to be 100 nM.
[0033] 3. Determining the testing time Because multiple enzymes exist in the RPA-CRISPR / Cas12a reaction system and they compete with each other, and the detection effect of Cas12a is better after incubation than before, the RPA-CRISPR / Cas12a detection system requires an appropriate reaction time: if it is too short, Cas12a will not be activated and trans-cleavage activity will be lost; if it is too long, enzyme activity will be unbalanced, leading to fluorescence signal attenuation or non-specific amplification. Therefore, it is necessary to determine the detection time.
[0034] To determine the optimal reaction time for the RPA-CRISPR / Cas12a fluorescence detection system, this study investigated the impact of reaction time on detection sensitivity, based on optimized concentration parameters. The optimal Cas12a and crRNA concentration combination obtained through previous orthogonal experiments was used, with the FAM-labeled reporter molecule concentration fixed at 100 nM. The reaction was performed in a real-time quantitative PCR instrument at a constant temperature of 37°C. Fluorescence signals from the FAM channel were continuously acquired at 1-minute intervals for 60 minutes. The rate of change of fluorescence signal intensity (ΔRFU / min) at different time points was calculated by analyzing the kinetic curve of fluorescence intensity over time. The plateau time of the reaction system was evaluated to determine the reaction time required for the fluorescence signal to slow down and reach a steady state.
[0035] Considering both the fluorescence slope and intensity, the optimal RPA reaction time for the RPA-CRISPR / Cas12a fluorescence detection system of the ITS1-5.8S rRNA-ITS2-28S rRNA (partial) target gene F1R1-crRNA1 was 30 min. Subsequent CRISPR / Cas12a detection efficiency decreased after 30 min, and the total reaction time was optimized to 60 min. Figure 5 As shown.
[0036] Considering both the slope and intensity of fluorescence, the optimal RPA reaction time for the F1R2-crRNA1 RPA-CRIAPSR / Cas12a fluorescence detection system was 20 min. The subsequent CRISPR / Cas12a detection system showed a flattening curve and decreased detection efficiency after 30 min. Therefore, the optimized total reaction time was determined to be 50 min. Figure 6 As shown.
[0037] Therefore, the optimal reaction time is 50-60 min.
[0038] 4. Determining the detection temperature To determine the optimal reaction temperature for the fluorescence reaction system, this study systematically investigated the effect of temperature on the trans-cleavage activity of the CRISPR / Cas12a system. The experiment used the previously screened RPA primers and the optimal concentration combination of Cas12a and crRNA, with the reporter molecule concentration fixed at 100 nM. Under constant reaction conditions, temperature gradients were set (34.2℃, 35.4℃, 37℃, 39℃, 40.7℃), with three parallel experiments at each temperature point. The reaction system was performed using a real-time quantitative PCR instrument, with FAM channel fluorescence signals continuously acquired at 1-minute intervals, using the selected reaction time. The reaction temperature was determined by analyzing the fluorescence kinetic curves, fluorescence intensity change rates, and plateau fluorescence values at different temperatures.
[0039] For the ITS1-5.8S rRNA-ITS2-28S rRNA (partial) gene, the RPA-CRISPR / Cas12a fluorescence detection system using F1R1-crRNA1 reached peak amplification efficiency at 37℃. Its fluorescence intensity (RFU = 25020) was 0.83 times higher than the lowest temperature of 34.2℃ (RFU = 13638). Figure 7 As shown.
[0040] The RPA-CRISPR / Cas12a fluorescence detection system based on the F1R2-crRNA1 combination reached peak amplification efficiency at 37℃. Its fluorescence intensity (RFU = 29125) was 0.76 times higher than the lowest temperature of 34.2℃ (RFU = 16583). Figure 8 As shown.
[0041] It can be seen that the preferred reaction temperature is 35.4℃-40.7℃, more preferably 37℃-39℃, and the optimal reaction temperature is 37℃.
[0042] Example 2: Methodological Evaluation of the RPA-CRISPR / Cas12a Detection System Samples: *Hookworm*, *Anisakis*, *Trichinella*, *Echinococcus granulosus*, *Echinococcus multivarioli*, and *Schistosoma japonicum* were obtained from the National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention. Fistula samples from 15 hookworm-positive patients and 22 negative controls were collected and provided by the Anhui Provincial Center for Disease Control and Prevention and the Chongqing Municipal Center for Disease Control and Prevention. Healthy stool samples (tested negative for infection using the Kato-Katz method) from laboratory staff were collected to simulate positive hookworm samples for experiments.
[0043] I. RPA-CRISPR / Cas12a Cross-Reaction Experiment Genomic DNA from *Hookworm* (20 ng / μL), *Trichinella spiralis* (30 ng / μL), *Anisakis* (30 ng / μL), *Echinococcus multilocularis* (20 ng / μL), *Echinococcus granulosus* (20 ng / μL), *Schistosoma japonicum* (18 ng / μL), and *Hookworm duodenalis* positive plasmid were amplified using different primers. The RPA amplification system was prepared and thoroughly mixed, then placed at the bottom of a 200 μL eight-row tube with a flat cap. To ensure independence between the RPA amplification system and the CRISPR / Cas12a detection system, the CRISPR / Cas12a detection system was placed on the tube cap and effectively separated from the CRISPR / Cas12a system using mineral oil to prevent premature cutting and reaction interference. All procedures were performed on ice. The reaction system was placed in a real-time PCR instrument and amplified at a constant temperature of 37°C. FAM fluorescence signals were collected every 1 minute during the reaction to monitor the amplification progress in real time.
[0044] The experiment selected *Hookworm*, *Trichinella spiralis*, *Anisakis*, *Echinococcus multilocularis*, *Echinococcus granulosus*, and *Schistosoma japonicum* as non-target controls, and amplification and detection were performed under the same reaction conditions. The results showed that F1R1-crRNA1 (targeting the ITS1-5.8S rRNA-ITS2-28S rRNA (partial) gene) was successfully amplified. Figure 9 Among them, NC: negative control; NTC: blank control), F1R2-crRNA1 ( Figure 10 In the RPA-CRISPR / Cas12a fluorescence detection system (NC: negative control; NTC: blank control), no specific amplification bands were observed in any non-target samples, and the fluorescence signal intensity was not significantly different from that of the negative control, demonstrating high specificity and the ability to effectively distinguish between target and non-target sequences.
[0045] II. Determination of the Limit of Detection for RPA-CRISPR / Cas12a The concentration of the target gene plasmid DNA from *Hookworm duodenalis* was determined using NanoDrop 2000. The formula was: Copy number (copies / µL) = 6.02 × 10⁻⁶. 23 ×Y (ng / µL) ×10 -9 Calculate the copy number using (plasmid base number × 660), and then dilute it to 10^6. 10 Copies / μL, stored at -20 ℃ for subsequent experiments.
[0046] The plasmid concentration was increased from 10 to 10 using a serial dilution method. 10 Dilute to 10 copies / μL -2 copies / μL, using different primer pairs at 8 different concentrations (concentration of 10).5 copies / μL, 10 4 copies / μL, 10 3 copies / μL, 10 2 copies / μL, 10 1 copies / μL, 10 0 copies / μL, 10 -1 copies / μL, 10 -2 A plasmid containing *Hookworm duodenalis* copies / μL was used as the template for RPA amplification and CRISPR / Cas12a detection. The RPA amplification system was thoroughly mixed at the bottom of a 200 μL eight-row tube with a flat cap. The CRISPR / Cas12a detection system was placed in the cap, and the two systems were separated by mineral oil. The reaction was performed at 37℃ using a quantitative PCR instrument (CFX96, Bio-Rad). FAM fluorescence was collected every 1 min to observe the fluorescence amplification results. The results showed: The limit of detection (LOD) of the RPA-CRISPR / Cas12a fluorescence detection system, based on the F1R1 primer pair and synergistic effect with crRNA1, for the ITS1-5.8S rRNA-ITS2-28S rRNA (partial) genes is 100 copies / μL. Figure 11 As shown, where 1:10 5 copies / μL; 2:10 4 copies / μL:;3:10 3 copies / μL; 4:10 2 copies / μL; 5:10 1 copies / μL:;6:10 0 copies / μL; 7:10 -1 copies / μL; 8:10 -2 copies / μL; NC: negative control; NTC: blank control; The limit of detection (LOD) of the RPA-CRISPR / Cas12a fluorescence detection system, based on the F1R2 primer pair and synergistic action with crRNA1, for the ITS1-5.8S rRNA-ITS2-28S rRNA (partial) genes is 10 copies / μL. Figure 12 As shown, where 1:10 5 copies / μL; 2:10 4 copies / μL:;3:10 3 copies / μL; 4:10 2copies / μL; 5:10 1 copies / μL:;6:10 0 copies / μL; 7:10 -1 copies / μL; 8:10 -2 copies / μL; NC: negative control; NTC: blank control.
[0047] III. Sensitivity and Specificity Validation The samples were numbered: samples 1-15 were hookworm positive samples, and samples 16-37 were hookworm negative samples.
[0048] 1. The RPA-CRISPR / Cas12a detection system of Example 1 was used to detect the samples. The RPA amplification system consisted of 2 μL of forward primer (F1), 2 μL of reaction primer (R2), both at a concentration of 10 μM, 25 μL of buffer, and 16 μL of ddH2O, for a total of 47 μL. The mixture was premixed and then transferred to a reaction unit containing lyophilized enzyme powder (recombinant enzyme UvsX, single-stranded binding protein, BsuDNA polymerase, and dNTP / dNTPase). After mixing by hand, the template containing the ITS1-5.8SrRNA-ITS2-28SrRNA (partial) gene plasmid was added. Finally, 3 µL of magnesium acetate (280 mmol / L) was added and placed at the bottom of the reaction tube. High-purity mineral oil (density 0.84 g / cm³) was added as a liquid phase barrier. The LbCasl2a nuclease (final concentration 50 nM), crRNA probe (ITS crRNA1, final concentration 50 nM), ssDNA reporter molecule (final concentration 100 nM), 2 µL RNase inhibitor (concentration 1.07 U / µL), and 7.5 µL buffer were mixed and then brought to a final volume of 25 µL with ddH2O. The mixture was then placed in the reaction tube cap. During the experiment, the RPA reaction system was placed at the bottom of the reaction tube, and after RPA amplification, it was mixed with the CRISPR / Cas12a detection system on the tube cap and centrifuged. The entire preparation process was performed on ice to ensure the stability of the experimental conditions. Detection was performed at 37℃ using a real-time PCR instrument, with fluorescence signals collected every 1 min. The fluorescence results are shown in the figure below. Figure 13 and 14 As shown, Figure 13 Samples 1-17 Figure 14 For samples 18-37, P: positive control; NC: negative control; NTC: blank control; results from blue light transillumination are as follows: Figure 15 and 16 As shown, Figure 15 Samples 1-17 Figure 16 Numbers 18-37, P: positive control; NC: negative control; NTC: blank control.
[0049] The results showed that among samples 1-15, a total of 11 samples tested positive for hookworm, namely: 1, 5-10, and 12-15. The remaining samples did not contain hookworm, and samples 16-37 did not contain hookworm.
[0050] 2. Samples were tested using the Kato-Katz method: The results of Kato-Katz microscopic examination showed that samples 1-15 contained hookworms, while samples 16-37 did not contain hookworms.
[0051] 3. Samples were tested using a semi-nested PCR method: The results showed that among samples 1-15, samples 3, 4 and 11 contained only American hookworm, samples 9 and 15 contained only duodenal hookworm, sample 2 did not contain hookworm, and samples 16-37 were samples without hookworm.
[0052] As can be seen, the RPA-CRISPR / Cas12a detection system of the present invention has a sensitivity and specificity of 100%, and a positive predictive value and a negative predictive value of 100%.
[0053] , , , .
[0054] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Any modifications, equivalent substitutions, improvements, etc., made within the spirit and principles of the present invention should be included within the scope of protection of the present invention.
Claims
1. An RPA-CRISPR / Cas12a detection system for hookworm of the duodenum, characterized in that, Using the ITS1-5.8S rRNA-ITS2-28S rRNA (partial) genes as detection targets, the detection system includes: The RPA amplification system contains RPA amplification primer pairs, wherein the RPA amplification primer pairs are the first primer pair F1R1 and / or the second primer pair F1R2; The CRISPR / Cas12a system contains crRNA, which is ITS crRNA1. The sequence of the upstream primer F1 of the first primer pair is: 5'-CTTACTGCTTGTGTTGGTGGTTGAGCATTAG-3'; The sequence of the downstream primer R1 of the first primer pair is: 5'-CTGTAGTAGATATAAACAACCCTGAACCAGAC-3'; The sequence of the upstream primer F1 of the second primer pair is: 5'-CTTACTGCTTGTGTTGGTGGTTGAGCATTAG-3'; The sequence of the downstream primer R2 of the second primer pair is: 5'-CGTCTGCAATTCGTGGTAAATAACGCAGCTA-3'; The sequence of ITS crRNA1 is: 5'-UAAUUUCUACUAAGUGUAGAUACGUUUAAUGUUUGCAGAAU-3'.
2. The detection system as described in claim 1, characterized in that, The RPA amplification system also includes positive plasmid standards, lyophilized enzyme complex, buffer, magnesium acetate, and ultrapure water.
3. The detection system as described in claim 2, characterized in that, The positive plasmid standard is a plasmid containing the ITS1-5.8SrRNA-ITS2-28SrRNA (partial) gene. The lyophilized enzyme complex includes recombinant enzyme, polymerase, single-chain binding protein, and dNTP / dNTPase.
4. The detection system as described in claim 1, characterized in that, The CRISPR / Cas12a system also includes ssDNA, Cas12a protein, RNase inhibitor, buffer, and ultrapure water. The ssDNA sequence is TTATT, with the 5' end labeled with the fluorescent reporter group FAM and the 3' end labeled with the fluorescent quencher group BHQ1.
5. The detection system as described in claim 4, characterized in that, In the CRISPR / Cas12a system, the concentration of Cas12a protein is 20-80 nM, the concentration of crRNA is 20-80 nM, the concentration of ssDNA is 100-140 nM, and the RNase inhibitor is 0.8-1.3 U / µL. The molar ratio of Cas12a protein to crRNA is 1:0.5-1.
5.
6. The application of the detection system as described in any one of claims 1-5 in the preparation of products for detecting hookworm of the duodenum.
7. A method for detecting hookworm in the duodenum for non-diagnostic purposes, characterized in that, Includes the following steps: S1. Extract DNA from the sample to be tested; S2. The obtained DNA is subjected to RPA amplification using the RPA amplification system described in claim 1 to obtain amplification products; S3. Add the amplification product obtained in step S2 to the CRISPR / Cas12a system described in claim 1, and perform a CRISPR / Cas12a reaction on the amplification product. S4. Determine whether hookworms of the duodenum are detected by fluorescence detection.
8. The detection method as described in claim 7, characterized in that, In step S2, the RPA amplification system is prepared as follows: after premixing the RPA amplification primer pair, buffer and ultrapure water, add the lyophilized enzyme complex, mix well and then add the positive plasmid standard and magnesium acetate to obtain the RPA amplification system. In step S3, the CRISPR / Cas12a system is prepared by mixing Cas12a protein, crRNA, ssDNA, RNase inhibitor, buffer, and ultrapure water evenly to obtain the CRISPR / Cas12a system.
9. The detection method as described in claim 8, characterized in that, In step S2, the positive plasmid standard is a plasmid containing the ITS1-5.8SrRNA-ITS2-28SrRNA (partial) gene. The lyophilized enzyme complex includes recombinant enzyme, polymerase, single-chain binding protein, and dNTP / dNTPase.
10. The detection method as described in claim 8, characterized in that, In step S3, the sequence of the ssDNA is TTATT, wherein the 5' end is labeled with the fluorescent reporter group FAM and the 3' end is labeled with the fluorescent quencher group BHQ1. The concentrations of Cas12a protein and crRNA were 20-80 nM, ssDNA was 100-140 nM, and RNase inhibitor was 0.8-1.3 U / µL. The molar ratio of Cas12a protein to crRNA was 1:0.5-1.5.
